Depression - Major Depressive DisorderNCT07427277
Depression Among Medical Students at Sohag University
An observational study of Depression - Major Depressive Disorder, run by Sohag University at 1 site in Egypt.
Trial summary
Introduction Depression is one of the most prevalent mental health disorders globally, significantly impacting individuals' quality of life, academic performance, and overall functioning. Read more about this study
- Who is it for?
- Ages 18 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- Depression - Major Depressive Disorder
- What is being tested?
- Questionnaire
- How many people
- 300 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Mar 2026to 28 Sep 2026
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 25 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: medical students at sohag university
Who may be able to join
- from 18 to 25 yrs medical student
Who cannot join
- less than 18 yrs
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
areeg abbas yossef, doctor contact
About this study
Introduction Depression is one of the most prevalent mental health disorders globally, significantly impacting individuals' quality of life, academic performance, and overall functioning. According to the World Health Organization (WHO), depression affects more than 264 million people worldwide, and it is considered a leading cause of disability. Among young adults, particularly students, the condition is increasingly common and often underdiagnosed and undertreated (1).
Medical students are at a disproportionately higher risk of depression compared to the general population due to the intense academic workload, pressure to perform, competitive environment, and exposure to human suffering during clinical training (2). A meta-analysis found that approximatel…
- Conditions
- Depression - Major Depressive Disorder
- Being tested
- Questionnaire
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnaireOther
The questionnaire was constructed to comprehensively assess depression symptoms alongside relevant socio-demographic and lifestyle factors that may be associated with mental health outcomes among medical students.
| Study group | Role | What they receive |
|---|---|---|
| medical student | no intervention Receives: Other: Questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
prevalence of depression
depression is common among medical student
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Feb 2026
- Study start1 Mar 2026 (estimated)
- Primary completion28 Sep 2026 (estimated)
- Study completion28 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Depression - Major Depressive DisorderStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 300 participants (estimated)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Basant Hemaid Mustafa, Sohag University
- Investigators
- Taher Abd - Elraheem, Professor, Study chair, Sohag UniversityOsama abdelrahem Mahmoud, Lecturer, Study director, Sohag UniversityOsama Eltaher, Lecturer, Study director, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07427277
- Sponsor's protocol ID
- Soh-Med-26-1-2MS
- Status last verified
- Feb 2026
- First submitted
- 16 Feb 2026
- Last updated
- 23 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: the aim of work and the result
Publications
Fawzy M, Hamed SA. Prevalence of psychological stress, depression and anxiety among medical students in Egypt. Psychiatry Res. 2017 Sep;255:186-194. doi: 10.1016/j.psychres.2017.05.027. Epub 2017 May 17.
PubMed 28575777Rotenstein LS, Ramos MA, Torre M, Segal JB, Peluso MJ, Guille C, Sen S, Mata DA. Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students: A Systematic Review and Meta-Analysis. JAMA. 2016 Dec 6;316(21):2214-2236. doi: 10.1001/jama.2016.17324.
PubMed 27923088Iqbal S, Gupta S, Venkatarao E. Stress, anxiety and depression among medical undergraduate students and their socio-demographic correlates. Indian J Med Res. 2015 Mar;141(3):354-7. doi: 10.4103/0971-5916.156571.
PubMed 25963497
Study at a glance
From the registry record, last updated by the sponsor on 23 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Depression Among Medical Students at Sohag University
- ClinicalTrials.gov ID
- NCT07427277
- Acronym / sponsor ID
- Soh-Med-26-1-2MS
- Conditions
- Depression - Major Depressive Disorder
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Mar 2026 (estimated)
- Primary completion
- 28 Sep 2026 (estimated)
- Study completion
- 28 Sep 2026 (estimated)
- First posted
- 23 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Introduction Depression is one of the most prevalent mental health disorders globally, significantly impacting individuals' quality of life, academic performance, and overall functioning. According to the World Health Organization (WHO), depression affects more than 264 million people worldwide, and it is considered a leading cause of disability. Among young adults, particularly students, the condition is increasingly common and often underdiagnosed and undertreated (1).
Medical students are at a disproportionately higher risk of depression compared to the general population due to the intense academic workload, pressure to perform, competitive environment, and exposure to human suffering during clinical training (2). A meta-analysis found that approximatel…
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Target follow-up
- 6 Months
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| medical student | – | Other: Questionnaireno intervention |
Who may qualify
- Ages
- 18 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- medical students at sohag university
Key inclusion criteria (1 listed)
- from 18 to 25 yrs medical student
Key exclusion criteria (1 listed)
- less than 18 yrs
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QuestionnaireThe questionnaire was constructed to comprehensively assess depression symptoms alongside relevant socio-demographic and lifestyle factors that may be associated with mental health outcomes among medical students. | Other | medical student |
Primary outcome
prevalence of depression
Time frame: 6 months
depression is common among medical student
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Feb 2026.
- Results publication: PubMed 28575777Fawzy M, Hamed SA. Prevalence of psychological stress, depression and anxiety among medical students in Egypt. Psychiatry Res. 2017 Sep;255:186-194. doi: 10.1016/j.psychres.2017.05.027. Epub 2017 May 17.
- Results publication: PubMed 27923088Rotenstein LS, Ramos MA, Torre M, Segal JB, Peluso MJ, Guille C, Sen S, Mata DA. Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students: A Systematic Review and Meta-Analysis. JAMA. 2016 Dec 6;316(21):2214-2236. doi: 10.1001/jama.2016.17324.
- Results publication: PubMed 25963497Iqbal S, Gupta S, Venkatarao E. Stress, anxiety and depression among medical undergraduate students and their socio-demographic correlates. Indian J Med Res. 2015 Mar;141(3):354-7. doi: 10.4103/0971-5916.156571.
- Individual participant dataSharing planned: Yes. the aim of work and the result
Related trials for Depression - Major Depressive Disorder
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
RecruitingPhase 4
Biomarker-Guided Antidepressant Selection
Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD)
Recruiting
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
Major Depressive Disorder, Apathy
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
Acute Intermittent Hypoxia Therapy for Depression
Major Depressive Disorder (MDD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
areeg abbas yossef, doctor contact
Taher Abd - Elraheem, Professor study chair
Sohag University
Osama abdelrahem Mahmoud, Lecturer study director
Sohag University
Osama Eltaher, Lecturer study director
Sohag University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Depression - Major Depressive Disorder, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 23 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact basant hemaid mustafa, resident (+201016912484 ext. 01000715833, basanthemaid2014@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
prevalence of depression (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07427277, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2026.